Rasika Setia, Mitu Dogra, Gokhula Prasath Thangavel, Ramesh Yadav, Amena Ebadur Rahman, Atul Bhasin, Rajesh Kumar Pande, Sandeep Nayar, R. K. Singal, Anil Vardani, Deepak Gargi Pande, R. N. Saini, Tribhuvan GulatI, Vivek Pal Singh, Sunny Kalra, Gagan Anand, Manish Garg, Santosh Ghai & N. M. Agarwal·International Blood Research & Reviews·2021
Background: COVID-19 pandemic continues threatening the world with no effective treatment to tackle the menace. Till date, there is conflicting evidence on efficacy of CP in reducing COVID-19 related mortality. The objective of this study was to see disease progression and 7, 14...
Open access
Research Article10.9734/ibrr/2021/v12i430158
Anti-CD19 chimeric antigen receptor (CAR) T-cells represent a novel immunotherapy that has shown remarkable success in the treatment of adult relapsed or refractory (R/R) B-cell non-Hodgkin's lymphoma, adult R/R mantle cell lymphoma, and R/R acute paediatric lymphoblastic leukaem...
Open access
Research Article10.9734/ibrr/2021/v12i430157
Statins are lipid-lowering agents. They also have immunomodulatory, anti-inflammatory, anti-angiogenic, and anti-proliferative functions. In this context, they are demonstrated to have beneficial effects on mortality in several malignancies including esophageal, breast, lung, liv...
Open access
Research Article10.9734/ibrr/2021/v12i430156
COVID-19 is a virus of the species of the Family coronaviridae known as as SARS-COV-2. This virus is easily contracted and/transmitted from an infected person to another healthy individual and has continued to spread rapidly. The aim of this review is to identify laboratory metho...
Open access
Research Article10.9734/ibrr/2021/v12i430155
Blood transfusion is oftentimes life-saving but associated with risks which ought to be disclosed by the health care provider as an ethical obligation and legal requirement. The practice of informed consent to transfusion medicine is quite new and few studies have comprehensively...
Open access
Research Article10.9734/ibrr/2021/v12i330154
Aims: To determine the survival of patients with acute lymphoblastic leukemia and COVID-19. Study Design: Prospective, analytical and relational. Place and Duration of Study: Hematology department, Hospital of Specialties, High Specialty Medical Unit, National Medical Center "Gra...
Open access
Research Article10.9734/ibrr/2021/v12i330153
Aim: The aim of this study was to assess the Gene Frequencies of Human Platelet Alloantigens in Rivers-State, Nigeria based on ABO/Rhesus blood groups distribution Study Design: A randomized controlled trial. Place and Duration of Study: Rivers State University Medical Centre,...
Open access
Research Article10.9734/ibrr/2021/v12i330152
Introduction: The COVID-19 pandemic raised a host of challenges to modern medicine. Key amongst these were in diagnostics, as most SARS-CoV-2 assays had been rapidly developed and released under emergency-use authorization with limited validation on clinical samples and secondly,...
Open access
Research Article10.9734/ibrr/2021/v12i330151
Chronic lymphocytic leukemia (CLL) in pediatric age is rare in the literature. It is a common disease of older adults, characterized by clonal proliferation and progressive accumulation of monoclonal B-cell lymphocytes. The diagnosis is established by immunophenotyping and progno...
Open access
Research Article10.9734/ibrr/2021/v12i330150
Aim: In this study, the haematology, serum antioxidant enzymes, and uric acid concentrations in prostatic disease patients attending the Nephrology Department of Abia State University Teaching Hospital, Aba were evaluated. Methodology: A total of one hundred and ten (110) adult m...
Open access
Research Article10.9734/ibrr/2021/v12i230149